-
Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial
van Driel, B. O., Schoonvelde, S. A. C., Borodzicz-Jazdzyk, S., Huurman, R., Visch, J., Robbers, L., Harms, H., Verhagen, J., Vermeer, A., van den Aardweg, J., van Rossum, A. C., Germans, T., Michels, M. & van der Velden, J., 1 Oct 2025, In: Cardiovascular Research. 121, 12, p. 1917-1928 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Metabolomics and metabolic therapy in hypertrophic cardiomyopathy
van Driel, B. O., 2025, 226 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Distinct metabolomic signatures in preclinical and obstructive hypertrophic cardiomyopathy
Schuldt, M., van Driel, B., Algül, S., Parbhudayal, R. Y., Barge-Schaapveld, D. Q. C. M., Güçlü, A., Jansen, M., Michels, M., Baas, A. F., van de Wiel, M. A., Nieuwdorp, M., Levin, E., Germans, T., Jans, J. J. M. & van der Velden, J., 1 Nov 2021, In: Cells. 10, 11, 2950.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
